Xencor Inc (XNCR)
24.10
+0.38
(+1.60%)
USD |
NASDAQ |
Nov 21, 16:00
24.10
0.00 (0.00%)
After-Hours: 20:00
Xencor Enterprise Value: 1.159B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.159B |
| November 20, 2024 | 1.132B |
| November 19, 2024 | 1.126B |
| November 18, 2024 | 1.095B |
| November 15, 2024 | 1.086B |
| November 14, 2024 | 1.117B |
| November 13, 2024 | 1.124B |
| November 12, 2024 | 1.131B |
| November 11, 2024 | 1.103B |
| November 08, 2024 | 1.125B |
| November 07, 2024 | 1.094B |
| November 06, 2024 | 1.059B |
| November 05, 2024 | 978.02M |
| November 04, 2024 | 978.02M |
| November 01, 2024 | 959.82M |
| October 31, 2024 | 942.32M |
| October 30, 2024 | 943.02M |
| October 29, 2024 | 981.11M |
| October 28, 2024 | 981.11M |
| October 25, 2024 | 952.43M |
| October 24, 2024 | 952.43M |
| October 23, 2024 | 947.53M |
| October 22, 2024 | 957.33M |
| October 21, 2024 | 946.83M |
| October 18, 2024 | 995.81M |
| Date | Value |
|---|---|
| October 17, 2024 | 966.42M |
| October 16, 2024 | 977.62M |
| October 15, 2024 | 950.33M |
| October 14, 2024 | 943.33M |
| October 11, 2024 | 961.52M |
| October 10, 2024 | 901.36M |
| October 09, 2024 | 846.78M |
| October 08, 2024 | 831.39M |
| October 07, 2024 | 834.89M |
| October 04, 2024 | 860.78M |
| October 03, 2024 | 834.89M |
| October 02, 2024 | 833.49M |
| October 01, 2024 | 846.08M |
| September 30, 2024 | 878.97M |
| September 27, 2024 | 925.09M |
| September 26, 2024 | 939.78M |
| September 25, 2024 | 890.83M |
| September 24, 2024 | 922.29M |
| September 23, 2024 | 927.19M |
| September 20, 2024 | 982.43M |
| September 19, 2024 | 991.52M |
| September 18, 2024 | 967.05M |
| September 17, 2024 | 980.33M |
| September 16, 2024 | 988.03M |
| September 13, 2024 | 1.010B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
479.85M
Minimum
Aug 07 2024
2.515B
Maximum
Feb 08 2021
1.261B
Average
1.190B
Median
Apr 12 2022
Enterprise Value Benchmarks
| Biogen Inc | 27.62B |
| Dynavax Technologies Corp | 1.084B |
| SINTX Technologies Inc | 1.094M |
| Fulcrum Therapeutics Inc | -97.04M |
| Moderna Inc | 7.852B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -45.14M |
| Revenue (Quarterly) | 10.71M |
| Total Expenses (Quarterly) | 72.99M |
| EPS Diluted (Quarterly) | -0.71 |
| Profit Margin (Quarterly) | -421.5% |
| Earnings Yield | -13.28% |
| Normalized Earnings Yield | -12.72 |